Document Detail


Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation.
MedLine Citation:
PMID:  20627196     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The aim of this study was to investigate the in vitro osteogenic activity of EGF in association with bone morphogenetic proteins BMP2 and BMP7.
METHODS: SaOS-2 (osteoblast-like cell line from human osteosarcoma) were cultured in the presence of EGF and BMPs for various culture periods to assess (a) cell proliferation by MTT assay, (b) Runx2, alkaline phosphatase (ALP) and osteocalcin (OC) mRNA expression using quantitative RT-PCR and ELISA, and (c) bone tissue mineralization using Alizarin Red staining.
RESULTS: EGF alone was able to stimulate osteoblast growth in a time-dependent manner. When mixed with BMP2, BMP7, and their combination, EGF greatly promoted osteoblast growth, compared to the BMP- and EGF-stimulated cells, suggesting a possible synergistic effect between EGF and BMPs on osteoblast growth. Stimulation with EGF, EGF/BMP2, and EGF/BMP2/BMP7 for 7 days upregulated Runx2 mRNA expression by the osteoblasts. EGF downregulated ALP mRNA expression, which was recovered when the BMP2/BMP7 combination was added to the osteoblast culture. Tested on OC mRNA expression, EGF had no effect and inhibited the enhancing effect of BMP2 and BMP7 on osteocalcin expression. The bone mineralization assay showed that EGF reduced both the number and size of the bone nodules. This reducing effect was observable even in the presence of BMP2 and BMP7.
CONCLUSION: This study demonstrated that EGF may act in the early phase to promote osteoblast growth and specific marker expression rather than the late phase involving cell differentiation/mineralization.
Authors:
Claude Laflamme; Sèverine Curt; Mahmoud Rouabhia
Related Documents :
15238146 - Synthesis of osteoprotegerin and rankl by megakaryocytes is modulated by oestrogen.
19394806 - Total flavonoids of herba epimedii improves osteogenesis and inhibits osteoclastogenesi...
16487626 - Effects of overexpression of basic helix-loop-helix transcription factor dec1 on osteog...
9700476 - Carboxyl-terminal parathyroid hormone fragments stimulate type-1 procollagen and insuli...
21764106 - Immunoelectron microscopic study of basp1 and marcks location in the early and late rat...
15221486 - Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene pr...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-11
Journal Detail:
Title:  Archives of oral biology     Volume:  55     ISSN:  1879-1506     ISO Abbreviation:  Arch. Oral Biol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-11     Completed Date:  2010-11-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0116711     Medline TA:  Arch Oral Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  689-701     Citation Subset:  D; IM    
Copyright Information:
Copyright 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Groupe de recherche en écologie buccale, Faculté de médecine dentaire, Pavillon de médecine dentaire, Université Laval, Québec, Canada G1K 7P4.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alkaline Phosphatase / biosynthesis
Analysis of Variance
Biological Markers / metabolism
Bone Morphogenetic Protein 2 / pharmacology,  physiology*
Bone Morphogenetic Protein 7 / pharmacology,  physiology*
Calcification, Physiologic / drug effects
Cell Line, Tumor
Cell Proliferation / drug effects
Core Binding Factor Alpha 1 Subunit / biosynthesis
Enzyme-Linked Immunosorbent Assay
Epidermal Growth Factor / pharmacology,  physiology*
Gene Expression Regulation
Humans
Osteoblasts / cytology*,  drug effects,  metabolism
Osteocalcin / biosynthesis*
Osteogenesis / drug effects*,  physiology
RNA / analysis
Reverse Transcriptase Polymerase Chain Reaction
Statistics, Nonparametric
Up-Regulation
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Bone Morphogenetic Protein 2; 0/Bone Morphogenetic Protein 7; 0/Core Binding Factor Alpha 1 Subunit; 0/RUNX2 protein, human; 104982-03-8/Osteocalcin; 62229-50-9/Epidermal Growth Factor; 63231-63-0/RNA; EC 3.1.3.1/Alkaline Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Shedding dynamics of Epstein-Barr virus: A type 1 carcinogen.
Next Document:  Erosion-inhibiting potential of a stannous chloride-containing fluoride solution under acid flow con...